Literature DB >> 10578323

Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression.

K Tanabe1, T Tokumoto, N Ishikawa, A Kanematsu, T Oshima, M Harano, M Inui, T Yagisawa, I Nakajima, S Fuchinoue, K Takahashi, H Toma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10578323     DOI： 10.1016/s0041-1345(99)00599-0

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

Review 1.  Current state of renal transplant immunosuppression: Present and future.

Authors:  Hari Varun Kalluri; Karen L Hardinger
Journal:  World J Transplant       Date:  2012-08-24

2.  Randomized comparative trial of mizoribine versus mycophenolate mofetil in combination with tacrolimus for living donor renal transplantation.

Authors:  Shiro Takahara; Kota Takahashi; Takahiro Akiyama; Kazuharu Uchida; Kazunari Tanabe; Noritoshi Amada; Hiroshi Toma
Journal:  Clin Exp Nephrol       Date:  2013-02-21       Impact factor: 2.801

3.  Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.

Authors:  Miao Zhang; Chang Ying Xing; Jia Liu
Journal:  Rheumatol Int       Date:  2013-06-25       Impact factor: 2.631

4.  The beneficial effect of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids on CMV infection in renal transplant recipients.

Authors:  Norio Yoshimura; Hidetaka Ushigome; Kiyokazu Akioka; Syuuji Nobori; Tomoyuki Suzuki; Kazuki Sakai; Masahiko Okamoto
Journal:  Clin Exp Nephrol       Date:  2012-08-02       Impact factor: 2.801

5.  Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis.

Authors:  Yukihiko Kawasaki; Kazuhide Suyama; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Clin Rheumatol       Date:  2010-09-16       Impact factor: 2.980

6.  Combination therapy of prednisolone and mizoribine improves cryoglobulinemic vasculitis with purpura and skin ulcers.

Authors:  Masahide Hamaguchi; Yutaka Kawahito; Yasunori Tsubouchi; Masataka Kohno; Aihiro Yamamoto; Hidetaka Ishino; Makoto Wada; Toshikazu Yoshikawa
Journal:  Clin Rheumatol       Date:  2006-04-14       Impact factor: 3.650

7.  Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial.

Authors:  Keiji Hirai; Susumu Ookawara; Taisuke Kitano; Haruhisa Miyazawa; Kiyonori Ito; Yuichirou Ueda; Yoshio Kaku; Taro Hoshino; Honami Mori; Izumi Yoshida; Kenji Kubota; Yasuyoshi Yamaji; Tetsuro Takeda; Yoshikazu Nakamura; Kaoru Tabei; Yoshiyuki Morishita
Journal:  Kidney Res Clin Pract       Date:  2017-06-30

Review 8.  Mizoribine: a new approach in the treatment of renal disease.

Authors:  Yukihiko Kawasaki
Journal:  Clin Dev Immunol       Date:  2009-12-13

Review 9.  Cyclophilin A as a target in the treatment of cytomegalovirus infections.

Authors:  Ashwaq A Abdullah; Rasedee Abdullah; Zeenathul A Nazariah; Krishnan N Balakrishnan; Faez Firdaus J Abdullah; Jamilu A Bala; Mohd-Azmi Mohd-Lila
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.